<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03102502</url>
  </required_header>
  <id_info>
    <org_study_id>EECP- 2</org_study_id>
    <nct_id>NCT03102502</nct_id>
  </id_info>
  <brief_title>Impact of Enhanced External Counterpulsation on Vascular Hemodynamics and Status</brief_title>
  <acronym>EECPVHS</acronym>
  <official_title>Study of the Effects of Enhanced External Counterpulsation on Vascular Hemodynamics and Status</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aimed to investigated the effect of Enhanced External Counterpulsation
      (EECP) on vascular hemodynamics and atherosclerosis, and the underlying shear stress related
      mechanisms
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with coronary heart disease will be randomized into two groups: standard medical
      treatment and standard medical treatment plus EECP intervention. Hemodynamic parameters,
      vascular status and function will be measured.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 10, 2017</start_date>
  <completion_date type="Anticipated">January 10, 2019</completion_date>
  <primary_completion_date type="Anticipated">October 10, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parallel: Patiants with coronary heart disease are assigned to two groups in parallel for the duration of the study.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in blood flow velocity</measure>
    <time_frame>At baseline, during EECP and week 7 (post intervention)</time_frame>
    <description>Change from baseline in blood flow velocity measured by color Doppler ultrasound system</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in vascular endothelial function</measure>
    <time_frame>At baseline and week 7 (post intervention)</time_frame>
    <description>Change from baseline in flow- mediated dilation (FMD) accessed by color Doppler ultrasound system</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in atherosclerosis</measure>
    <time_frame>At baseline and week 7 (post intervention)</time_frame>
    <description>Change from baseline in atherosclerosis : plaque of common carotid artery, carotid intima- media thickness, pulse wave velocity</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Coronary Heart Disease</condition>
  <arm_group>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients receive a total of 35-36 hours of EECP treatment on top of guideline- driven standard medical therapy for coronary heart disease, 1-hour sessions every day over a 7-week period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients receive guideline- driven standard medical therapy for 7 weeks without Enhanced External Counterpulsation intervention.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EECP</intervention_name>
    <description>Enhanced external counterpulsation (EECP) is a technique for assisting the circulation by decreasing the afterload of the left ventricle and augmenting the diastolic pressure externally by applying a negative pressure to the lower extremities during cardiac systole. EECP therapy is done by sequential inflation of 3 sets of cuffs wrapped around the lower extremities during diastole and deflation of the cuffs during systole. EECP enhances the aortic diastolic blood flow and coronary perfusion, leading to increased arterial wall shear stress in a pulsatile manner.</description>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <other_name>Enhanced External Counterpulsation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Medical therapy</intervention_name>
    <description>Guideline- driven standard medical treatment including statins,antiplatelet drugs（aspirin or Clopidogrel ）, anti-ischemic drugs （Nitroglycerin）</description>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <arm_group_label>Control</arm_group_label>
    <other_name>Guideline- driven medical therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  More than 50% stenosis of left main trunk and 3 epicardial coronary arteries and their
             large branches showed by coronary angiography

          -  Or history of myocardial infarction

          -  Or history of prior revascularization

          -  Signed informed consent to participate in the study

        Exclusion Criteria:

          -  Clinically significant valvular heart disease

          -  Aortic aneurysm

          -  Congenital heart disease

          -  Acute myocarditis

          -  Arrythmias significantly interfere with the triggering of the EECP device

          -  History of cerebral hemorrhage

          -  Hemorrhagic disease

          -  Lower limb infection, phlebitis

          -  Deep venous thrombosis

          -  Malignant disease

          -  INR &gt; 2.5

          -  Uncontrolled hypertension, defined as SBP &gt; 180mmHg or DBP &gt; 110mmHg

          -  Pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Zhang, M. D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Zhensheng Zheng, M. D.</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yan Zhang, M. D.</last_name>
    <phone>8620-87755766</phone>
    <phone_ext>8161</phone_ext>
    <email>zhyan3@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Qiang Xie, M. D.</last_name>
    <phone>8620-87755766</phone>
    <phone_ext>8161</phone_ext>
    <email>qiangxie@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital, Sun Yat- sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weiwei Zhang, PhD</last_name>
      <phone>020-87334871</phone>
      <email>zhweiw2@mail.sysu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Xiaoxu Zhou, PhD</last_name>
      <phone>020-87780263</phone>
      <email>xiaoxuzou_sysu@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. J Am Coll Cardiol. 2007 Oct 16;50(16):1523-31. Epub 2007 Oct 1. Review. Erratum in: J Am Coll Cardiol. 2007 Dec 18;50(25):2441.</citation>
    <PMID>17936150</PMID>
  </reference>
  <reference>
    <citation>Nichols WW, Estrada JC, Braith RW, Owens K, Conti CR. Enhanced external counterpulsation treatment improves arterial wall properties and wave reflection characteristics in patients with refractory angina. J Am Coll Cardiol. 2006 Sep 19;48(6):1208-14. Epub 2006 Aug 28.</citation>
    <PMID>16979007</PMID>
  </reference>
  <reference>
    <citation>Braith RW, Conti CR, Nichols WW, Choi CY, Khuddus MA, Beck DT, Casey DP. Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study. Circulation. 2010 Oct 19;122(16):1612-20. doi: 10.1161/CIRCULATIONAHA.109.923482. Epub 2010 Oct 4.</citation>
    <PMID>20921442</PMID>
  </reference>
  <reference>
    <citation>Zhang Y, He X, Chen X, Ma H, Liu D, Luo J, Du Z, Jin Y, Xiong Y, He J, Fang D, Wang K, Lawson WE, Hui JC, Zheng Z, Wu G. Enhanced external counterpulsation inhibits intimal hyperplasia by modifying shear stress responsive gene expression in hypercholesterolemic pigs. Circulation. 2007 Jul 31;116(5):526-34. Epub 2007 Jul 9.</citation>
    <PMID>17620513</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2017</study_first_submitted>
  <study_first_submitted_qc>March 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2017</study_first_posted>
  <last_update_submitted>April 18, 2018</last_update_submitted>
  <last_update_submitted_qc>April 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Yan Zhang</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Coronary Heart Disease</keyword>
  <keyword>Atherosclerosis</keyword>
  <keyword>Vascular Endothelium</keyword>
  <keyword>Counterpulsation, External</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

